Literature DB >> 14656809

Giving aspirin and ibuprofen after myocardial infarction.

Stephen E Kimmel, Brian L Strom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14656809      PMCID： PMC286284          DOI： 10.1136/bmj.327.7427.1298

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  12 in total

Review 1.  Clinical practice. Aspirin for primary prevention of coronary events.

Authors:  Michael S Lauer
Journal:  N Engl J Med       Date:  2002-05-09       Impact factor: 91.245

2.  Aspirin, ibuprofen, and mortality after myocardial infarction: retrospective cohort study.

Authors:  Jeptha P Curtis; Yongfei Wang; Edward L Portnay; Frederick A Masoudi; Edward P Havranek; Harlan M Krumholz
Journal:  BMJ       Date:  2003-12-06

3.  Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.

Authors:  F Catella-Lawson; M P Reilly; S C Kapoor; A J Cucchiara; S DeMarco; B Tournier; S N Vyas; G A FitzGerald
Journal:  N Engl J Med       Date:  2001-12-20       Impact factor: 91.245

Review 4.  Exploring the link between gastrointestinal complications and over-the-counter analgesics: current issues and considerations.

Authors:  D Stiel
Journal:  Am J Ther       Date:  2000-03       Impact factor: 2.688

Review 5.  Aspirin as an antiplatelet drug.

Authors:  C Patrono
Journal:  N Engl J Med       Date:  1994-05-05       Impact factor: 91.245

6.  Adherence to aspirin in the prevention of myocardial infarction. The Physicians' Health Study.

Authors:  R J Glynn; J E Buring; J E Manson; F LaMotte; C H Hennekens
Journal:  Arch Intern Med       Date:  1994 Dec 12-26

7.  Compliance with aspirin or placebo in the Hypertension Optimal Treatment (HOT) study.

Authors:  B Waeber; G Leonetti; R Kolloch; G T McInnes
Journal:  J Hypertens       Date:  1999-07       Impact factor: 4.844

8.  Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs.

Authors:  Tobias Kurth; Robert J Glynn; Alexander M Walker; K Arnold Chan; Julie E Buring; Charles H Hennekens; J Michael Gaziano
Journal:  Circulation       Date:  2003-08-25       Impact factor: 29.690

9.  Frequency of use of acetaminophen, nonsteroidal anti-inflammatory drugs, and aspirin in US women.

Authors:  Gary C Curhan; Andrea J Bullock; Susan E Hankinson; Walter C Willett; Frank E Speizer; Meir J Stampfer
Journal:  Pharmacoepidemiol Drug Saf       Date:  2002-12       Impact factor: 2.890

10.  Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage.

Authors:  C M Wilcox; K A Shalek; G Cotsonis
Journal:  Arch Intern Med       Date:  1994-01-10
View more
  3 in total

Review 1.  Cardiology.

Authors:  Tom Fahey; Knut Schroeder
Journal:  Br J Gen Pract       Date:  2004-09       Impact factor: 5.386

2.  Interference of NSAIDs with the thrombocyte inhibitory effect of aspirin: a placebo-controlled, ex vivo, serial placebo-controlled serial crossover study.

Authors:  I L Meek; H E Vonkeman; J Kasemier; K L L Movig; M A F J van de Laar
Journal:  Eur J Clin Pharmacol       Date:  2012-08-14       Impact factor: 2.953

Review 3.  Aspirin, NSAIDs, and COX-2 inhibitors in cardiovascular disease: possible interactions and implications for treatment of rheumatoid arthritis.

Authors:  Tobias Kurth; Charles H Hennekens; Julie E Buring; J Michael Gaziano
Journal:  Curr Rheumatol Rep       Date:  2004-10       Impact factor: 4.592
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.